On this page

Follistim

follitropin beta

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Follistim
Proper name
follitropin beta
Licence type
351(a)
BLA number
020582
Applicant
Organon USA Inc., a subsidiary of Merck & Co., Inc.
Center
CDER
Presentations
2
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
150IU For Injection Subcutaneous, Intramuscular Single-Dose Vial Disc September 29, 1997
75IU For Injection Subcutaneous, Intramuscular Single-Dose Vial Disc September 29, 1997

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity